SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
9441780
Source:
http://linkedlifedata.com/resource/pubmed/id/9441780
Search
Subject
(
55
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008838
,
umls-concept:C0087111
,
umls-concept:C0205179
,
umls-concept:C0279024
,
umls-concept:C0302592
,
umls-concept:C1517927
,
umls-concept:C2349975
pubmed:issue
3
pubmed:dateCreated
1998-2-4
pubmed:abstractText
To evaluate the efficacy and toxicity of interferon-alpha-2b (IFN-alpha) and cisplatin given concomitantly with radiation therapy (RT) in the treatment of locally advanced cervical carcinoma.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0365304
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha
,
http://linkedlifedata.com/resource/pubmed/chemical/Radiation-Sensitizing Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2b
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0090-8258
pubmed:author
pubmed-author:BeddoeA MAM
,
pubmed-author:CohenCC
,
pubmed-author:DeWyngaertJ KJK
,
pubmed-author:DottinoPP
,
pubmed-author:JenningsT STS
,
pubmed-author:StockR GRG
,
pubmed-author:TerkMM
pubmed:issnType
Print
pubmed:volume
67
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
309-15
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:9441780-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:9441780-Brachytherapy
,
pubmed-meshheading:9441780-Chemotherapy, Adjuvant
,
pubmed-meshheading:9441780-Cisplatin
,
pubmed-meshheading:9441780-Disease-Free Survival
,
pubmed-meshheading:9441780-Female
,
pubmed-meshheading:9441780-Follow-Up Studies
,
pubmed-meshheading:9441780-Humans
,
pubmed-meshheading:9441780-Interferon-alpha
,
pubmed-meshheading:9441780-Neoplasm Staging
,
pubmed-meshheading:9441780-Radiation-Sensitizing Agents
,
pubmed-meshheading:9441780-Radiotherapy, Adjuvant
,
pubmed-meshheading:9441780-Radiotherapy Dosage
,
pubmed-meshheading:9441780-Recombinant Proteins
,
pubmed-meshheading:9441780-Treatment Outcome
,
pubmed-meshheading:9441780-Uterine Cervical Neoplasms
pubmed:year
1997
pubmed:articleTitle
Enhanced radiosensitization with interferon-alpha-2b and cisplatin in the treatment of locally advanced cervical carcinoma.
pubmed:affiliation
Department of Radiation Oncology, Mount Sinai School of Medicine, New York, New York 10029, USA.
pubmed:publicationType
Journal Article